C12P 21 - Preparation of peptides or proteins

Patents for C12P 21 - Preparation of peptides or proteins (112,499)
08/2006
08/29/2006	US7098012 DNA demethylase, therapeutic and diagnostic uses thereof
08/29/2006	US7098011 chimeric sequences encoding all or a substantial portion of the enzymes, in sense or antisense orientation, wherein expression of the chimeric sequence results in production of altered levels of the enzyme in a transformed host cell
08/29/2006	US7098010 galactose oxidase having improved thermal stability
08/29/2006	US7098007 Screening analysis using nucleic acids; antibodies, transgenic animals; antiproliferative agents; induction cell cycle delay
08/29/2006	US7098006 preparation of an antibody chain having a variable domain comprising three complementarity determining regions
08/29/2006	US7098004 Isolated polypeptide of the stratum corneum and its use
08/29/2006	US7098003 PRO 1384 nucleic acids
08/29/2006	US7098002 Preparation of biologically active molecules
08/29/2006	US7098001 Polypeptides having dipeptidyl aminopeptidase activity and nucleic acids encoding same
08/29/2006	US7097991 screening for an agent that modulates capsaicin receptor function
08/29/2006	US7097989 Complement C3 precursor biopolymer markers predictive of type II diabetes
08/29/2006	US7097986 For use in pharmaceutical and diagnostic formulations
08/29/2006	US7097985 for the treatment of leukemia, tumors, chronic infections, autoimmune disease, fibrotic disorders, wound healing and psoriasis
08/29/2006	US7097846 35 kD tumor associated protein antigen: uses and methods of detection
08/29/2006	US7097844 T helper cell epitopes
08/29/2006	US7097839 A conjugated compound contains antibody or a Fab, and a radiostable therapeutic active agent; for diagnosis/therapy of colorectal cancer; biological conjugated drugs
08/29/2006	US7097835 A biological conjugated immunotoxins, comprising a cytotoxin conjugated to an antibody, specifical binding a cell surface-accessible epitope of a vesicular transporter protein; selectively killing, protecting neuronal cell
08/29/2006	US7097834 Osteoprotegerin binding proteins
08/29/2006	CA2318851C Recombinant human mannan-binding proteins and process for producing the same
08/29/2006	CA2053585C Antibody production in chinese hamster ovary cells
08/24/2006	WO2006088951A2 Cd38 modulated chemotaxis
08/24/2006	WO2006088494A2 Identification and engineering of antibodies with variant fc regions and methods of using the same
08/24/2006	WO2006088447A1 An anti-cd137 antibody as an agent in the treatement of cancer and glycosylation variants thereof
08/24/2006	WO2006088198A1 Method of producing protein by using hamster igf-1
08/24/2006	WO2006088110A1 Novel protein promoting carbonic acid fixation and method of fixing carbonic acid by using the protein
08/24/2006	WO2006087821A1 Method of detecting reaction of protein with sample
08/24/2006	WO2006053299A3 Site-directed modification of fviii
08/24/2006	WO2006029078A3 Targeting transducible molecules to specific cell types
08/24/2006	WO2005093050A3 Cellulase fusion protein and heterologous cellulase fusion construct encoding the same
08/24/2006	WO2005051973A3 Peptides derived from natural cytotoxicity receptors and methods of use thereof
08/24/2006	WO2005027725A3 Determination of ions using ion-sensitive enzymes
08/24/2006	WO2004043397A3 Compositions and methods for the treatment of rheumatoid arthritis
08/24/2006	WO2003087300A3 Secreted proteins
08/24/2006	US20060191027 Cystine-knot polypeptides: Cloaked-2 molecules and uses thereof
08/24/2006	US20060191024 Method for preparing anti-MIF antibodies
08/24/2006	US20060189798 Novel steroid/thyroid hormone receptor-related gene, which is inappropriately expressed in human heptocellular carcinoma, and which is a retinoic acid receptor
08/24/2006	US20060189791 Recombinant expression of streptococcus pyogenes cysteine protease and immunogenic compositions thereof
08/24/2006	US20060189531 Thrombopoietic compounds
08/24/2006	US20060189530 Neuropeptide Y receptor Y5 and nucleic acid sequences
08/24/2006	US20060189525 DADD, death activator death domain protein
08/24/2006	US20060189515 Drug delivery across the blood-brain barrier using polypeptides; neurological diseases; aprotinin
08/24/2006	US20060189001 Ssx-2 peptides presented by hla class II molecules
08/24/2006	US20060188976 Mutant protein having the peptide-synthesizing activity
08/24/2006	US20060188974 Human protein kinases and protein kinase-like enzymes
08/24/2006	US20060188964 Processing for producing and crystallizing G-protein coupled receptors
08/24/2006	US20060188963 Collectin-complement activating protein chimeras
08/24/2006	US20060188962 19 human secreted proteins
08/24/2006	US20060188961 Vaccine; inducing an immune response; infectious diseases, which can be caused by more than one strain, clade, variant, subtype or serotype of infectious disease causing microorganism; reliable vaccination against all Dengue virus serotypes
08/24/2006	US20060188960 Chimeric histamine H3 receptor
08/24/2006	US20060188959 Crystal structure of worm NitFhit reveals that a Nit tetramer binds tow Fhit dimers
08/24/2006	US20060188958 Artificial enzyme and method for producing the same
08/24/2006	US20060188957 Novel TNF receptor death domain ligand proteins and inhibitors of ligand binding
08/24/2006	US20060188956 Relaxin3-gpcr135 complexes and their production and use
08/24/2006	US20060188947 Reagent for producing a protein chip
08/24/2006	US20060188937 G-protein estrogen membrane receptor
08/24/2006	US20060188935 Protein and its use in diagnosing Alzheimer's disease
08/24/2006	US20060188933 IRAK-M is a negative regulator of toll-like receptor signaling
08/24/2006	US20060188930 Isolated fluorescent protein from clytia gregaria cgfp and use thereof
08/24/2006	US20060188926 Nucleic acid sequences and methods for identifying compounds that affect RNA/RNA binding protein interactions and mRNA functionality
08/24/2006	US20060188924 TCL-1 gene and protein and related methods and compositions
08/24/2006	US20060188914 Secreted and transmembrane polypeptides and nucleic acids encoding the same
08/24/2006	US20060188903 Implantation serine proteinases
08/24/2006	US20060188516 Chlamydia trachomatis antigens
08/24/2006	US20060188510 Antibody against secreted N-terminal peptide of GPC3 present in blood or C-terminal peptide of GPC3
08/24/2006	US20060188502 Nucleic acid encoding a chimeric, humanized or CDR-grafted antibody that binds and inhibits the activity of human IL-6
08/24/2006	US20060188477 Use of interferon alpha 5 in the treatment of viral liver diseases
08/24/2006	US20060188474 Interleukin 1beta protease and interleukin 1beta protease inhibitors
08/24/2006	DE60115613T2 Herstellung von rekombinanten muteine des blutgerinnungsfaktors viii in humanen zellinien Production of recombinant muteins of the blood coagulation factor viii in human cell lines
08/24/2006	CA2598570A1 Methods for producing proteins using hamster igf-1
08/24/2006	CA2598522A1 Human monoclonal antibodies to prostate specific membrane antigen (psma)
08/24/2006	CA2597924A1 Anti-cd19 antibodies and uses in oncology
08/24/2006	CA2597922A1 Cd38 modulated chemotaxis
08/24/2006	CA2597605A1 Pharmaceutical compositions for treating or preventing bone conditions
08/24/2006	CA2596509A1 Interleukin-17f antibodies and other il-17f signaling antagonists and uses therefor
08/24/2006	CA2573659A1 Identification and engineering of antibodies with variant fc regions and methods of using same
08/23/2006	EP1693456A1 Gene encoding g protein-coupled receptor and gene product thereof
08/23/2006	EP1693385A1 Humanized anti-cd47 antibody
08/23/2006	EP1693384A2 Functional immunoglobulins against human serum albumin, fragments thereof, library thereof and methods of production thereof
08/23/2006	EP1692313A2 Methods for purifying pertussis toxin and peptides useful therefor
08/23/2006	EP1692282A1 Improved protein expression systems
08/23/2006	EP1692269A1 Production of diphtheria toxin
08/23/2006	EP1692182A2 Cd20 antibodies with increased fc receptor binding affinity and effector function
08/23/2006	EP1692180A2 Anti-il-20 antibodies and binding partners and methods of using in inflammation
08/23/2006	EP1692160A2 Fgf-5 binding and supported peptides
08/23/2006	EP1692159A2 Tgf-beta binding and supported peptides
08/23/2006	EP1692158A2 Tgf-beta binding and supported peptides
08/23/2006	EP1692156A2 Self-assembling split-fluorescent protein systems
08/23/2006	EP1532261A4 Methods and dna constructs for high yield production of polypeptides
08/23/2006	EP1358318B1 Hybridoma cell line g250 and its use for producing monoclonal antibodies
08/23/2006	EP1334122B1 Nucleic acids encoding stichodactylidae chromoproteins
08/23/2006	EP1062346B1 Gene encoding labyrinthin, a marker for cancer
08/23/2006	EP1012181B1 Surface antigens and proteins useful in compositions for the diagnosis and prevention of lyme disease
08/23/2006	EP0952980B1 Acyl transfer with stabilised transition complex using catalyst with catalytic imidazole (e.g. histidine) function
08/23/2006	CN1823169A Process for manufacture of nematode-extracted anticoagulant protein (NAP)
08/23/2006	CN1823089A Method for producing a polypeptide
08/23/2006	CN1821421A Method for high efficiency extracting collagen by alkali swelling acid enzymolysis
08/23/2006	CN1821398A Process for preparing heat-labile enterotoxin of E, coli
08/23/2006	CN1820734A Treatment with anti-erbb2 antibodies
08/23/2006	CN1271210C Neutralization monoclonal antibody of white spot syndrome virus and preparation method
08/23/2006	CN1271205C Reconstituted human anti-HM1.24 antibody

1 ... 390 391 392 393 394 395 396 397 398 399 400 401 402 403 404 405 406 407 408 409 410 ... 1125